Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avricore Health (AVCRF) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Avricore Health (AVCRF) over the last 17 years, with Q3 2025 value amounting to $73.6 million.

  • Avricore Health's Shares Outstanding (Weighted Average) fell 1.98% to $73.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.6 million, marking a year-over-year decrease of 1.98%. This contributed to the annual value of $73.3 million for FY2024, which is 70.66% down from last year.
  • As of Q3 2025, Avricore Health's Shares Outstanding (Weighted Average) stood at $73.6 million, which was down 1.98% from $73.1 million recorded in Q2 2025.
  • Avricore Health's 5-year Shares Outstanding (Weighted Average) high stood at $77.1 million for Q1 2022, and its period low was $65.7 million during Q1 2021.
  • In the last 5 years, Avricore Health's Shares Outstanding (Weighted Average) had a median value of $73.6 million in 2025 and averaged $73.5 million.
  • Per our database at Business Quant, Avricore Health's Shares Outstanding (Weighted Average) surged by 8261.36% in 2021 and then plummeted by 472.81% in 2023.
  • Quarter analysis of 5 years shows Avricore Health's Shares Outstanding (Weighted Average) stood at $73.5 million in 2021, then decreased by 1.88% to $72.1 million in 2022, then rose by 1.44% to $73.1 million in 2023, then decreased by 1.81% to $71.8 million in 2024, then grew by 2.47% to $73.6 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $73.6 million for Q3 2025, versus $73.1 million for Q2 2025 and $70.6 million for Q1 2025.